Replimune News - REPL

Company Name	Stock Ticker Symbol	Market	Type
Replimune Group Inc	REPL	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.08	-1.25%	6.33	16:25:32

Open Price	Low Price	High Price	Close Price	Prev Close
6.41	6.20	6.66	6.33	6.41

more quote information »

Recent News

Date	Time	Source	Heading
4/07/2024	17:00	GLOBE	Interim Results from the ARTACUS Clinical Trial of RP1..
4/04/2024	08:00	GLOBE	Replimune Announces Inducement Grants Under Nasdaq Listing..
3/26/2024	07:30	GLOBE	Replimune Announces Appointment of Sushil Patel to CEO and..
3/06/2024	08:00	GLOBE	Replimune to Present at the American Association for Cancer..
3/05/2024	08:00	GLOBE	Replimune to Present at Three Upcoming Investor Conferences
2/14/2024	07:21	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/08/2024	08:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/08/2024	08:05	EDGAR2	Form 8-K - Current report
2/08/2024	08:00	GLOBE	Replimune Reports Fiscal Third Quarter 2024 Financial..
1/16/2024	04:06	PRNUS	DISCO Pharmaceuticals launches as the surfaceome company..
1/16/2024	03:59	PRNUS	DISCO Pharmaceuticals launches as the surfaceome company..
1/08/2024	08:00	EDGAR2	Form 8-K - Current report
12/28/2023	08:00	GLOBE	Replimune to Present at the 42nd Annual J.P. Morgan..
12/26/2023	17:15	EDGAR2	Form 8-K - Current report
12/05/2023	07:19	EDGAR2	Form 8-K - Current report
12/05/2023	07:00	GLOBE	Replimune Shares Initial Primary Analysis Results from..
11/17/2023	20:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/17/2023	20:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/08/2023	09:10	GLOBE	Replimune Presents Updated Data on RP2 in Uveal Melanoma..
11/07/2023	17:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	08:15	EDGAR2	Form 8-K - Current report
11/07/2023	08:00	GLOBE	Replimune Reports Fiscal Second Quarter 2024 Financial..
11/03/2023	19:30	GLOBE	Replimune Presents Updated Interim Results from the ARTACUS..
9/20/2023	20:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/20/2023	20:03	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
9/19/2023	16:01	GLOBE	Replimune Announces Inducement Grants Under Nasdaq Listing..
9/19/2023	08:15	EDGAR2	Form 8-K - Current report
9/19/2023	08:00	GLOBE	Replimune Announces Appointment of Emily Hill as Chief..
9/13/2023	21:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/07/2023	09:17	EDGAR2	Form 8-K - Current report
8/24/2023	20:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/15/2023	20:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/03/2023	09:04	EDGAR2	Form 8-K - Current report
8/03/2023	08:45	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
8/03/2023	08:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	08:09	EDGAR2	Form 8-K - Current report
8/03/2023	08:00	GLOBE	Replimune Reports Fiscal First Quarter 2024 Financial..
8/01/2023	08:00	GLOBE	Replimune to Present at Two Upcoming Investor Conferences
7/31/2023	16:01	BW	Replimune and Incyte Enter into Clinical Trial Collaboration..
7/26/2023	20:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
7/26/2023	17:08	EDGAR2	Form ARS - Annual Report to Security Holders
7/26/2023	17:06	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
7/26/2023	17:02	EDGAR2	Form DEF 14A - Other definitive proxy statements
7/20/2023	08:56	EDGAR2	Form 8-K - Current report
7/20/2023	08:00	GLOBE	Replimune Announces Sander Slootweg will Depart from its..
7/11/2023	21:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/10/2023	16:27	EDGAR2	Form 144 - Report of proposed sale of securities
6/06/2023	10:00	GLOBE	Replimune Presents Initial RP1 Data from the ARTACUS..
6/05/2023	08:00	GLOBE	Replimune Appoints Veleka R. Peeples-Dyer to its Board of..
6/03/2023	14:15	GLOBE	Replimune Presents RP1 Data from the IGNYTE anti-PD1 Failed..